IMU 9.26% 5.9¢ imugene limited

Ann: Clinical Trial Supply Agreement with Merck KGaA and Pfizer, page-140

  1. 135 Posts.
    lightbulb Created with Sketch. 24
    I would suggest that any hostile takeover would not fetch $3.5B, it would be a lot higher. I think you would find management organising a 'white knight' of sorts to either make sure the share price goes through the roof and they vacuum shares up or could defend it from this. Obviously it is a great end game to be taken out by them for outrageous multiples but I don't think it would be a hostile event due to the shit-housery that requires.

    Just my thoughts anyway. Glad to be in this one for a few months now think management are kicking some serious butt.

    Looking forward to this being well over $5 before a takeover is on the cards. Hoping that these trials come back with strong results.

    Cheers,
    Gazza69
 
watchlist Created with Sketch. Add IMU (ASX) to my watchlist
(20min delay)
Last
5.9¢
Change
0.005(9.26%)
Mkt cap ! $433.6M
Open High Low Value Volume
5.5¢ 5.9¢ 5.4¢ $1.489M 25.99M

Buyers (Bids)

No. Vol. Price($)
2 35252 5.9¢
 

Sellers (Offers)

Price($) Vol. No.
6.0¢ 1753430 24
View Market Depth
Last trade - 16.10pm 12/07/2024 (20 minute delay) ?
IMU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.